Table 2. Outcome analysis.
Acute Stenting with Tirofiban n = 60 | Acute MCA thrombectomy without Tirofiban n = 135 | After propensity score adjustment, OR with CI and p-value | |
---|---|---|---|
Discharge mRS 0–3 | 32 (53%) | 60 (44%) | OR 3.164 [1.306–7.668]; p = 0.011 |
90 days mRS 0–3 | 37 (62%) | 66 (49%) | OR 2.129 [0.930–4.872]; p = 0.074 |
Reinfarction | 2 (3%) | 1 (1%) | n.a.* |
Any ICH | 12 (20%) | 27 (20%) | OR 0.863 [0.370–2.013]; p = 0.734 |
Symptomatic ICH | 5 (8%) | 8 (6%) | OR 1.706 [0.388–7.505]; p = 0.480 |
Death within hospital stay | 6 (10%) | 14 (10%) | OR 3.292 [0.797–13.597]; p = 0.100 |
* numbers to small